Robert Kramer

2020 - Emergent BioSolutions

In 2020, Robert Kramer earned a total compensation of $5.6M as President and Chief Executive Officer at Emergent BioSolutions, a 51% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$1,225,020
Option Awards$1,392,416
Salary$893,860
Stock Awards$2,050,007
Other$8,675
Total$5,569,978

Kramer received $2.1M in stock awards, accounting for 37% of the total pay in 2020.

Kramer also received $1.2M in non-equity incentive plan, $1.4M in option awards, $893.9K in salary and $8.7K in other compensation.

Rankings

In 2020, Robert Kramer's compensation ranked 1,929th out of 13,090 executives tracked by ExecPay. In other words, Kramer earned more than 85.3% of executives.

ClassificationRankingPercentile
All
1,929
out of 13,090
85th
Division
Manufacturing
750
out of 5,620
87th
Major group
Chemicals And Allied Products
270
out of 2,253
88th
Industry group
Drugs
227
out of 1,953
88th
Industry
Pharmaceutical Preparations
160
out of 1,458
89th

Pay ratio

Robert Kramer's Pay$5,569,978
Median Employee's Pay$128,545
Pay Ratio

43

to 1

In 2020, the annual total compensation of Robert Kramer was $5,569,978.

The annual total compensation of the median employee at Emergent BioSolutions was $128,545.

The ratio of Robert Kramer's pay to the pay of median employee was therefore 43 to one.

Source: SEC filing on April 9, 2021.

Kramer's colleagues

We found four more compensation records of executives who worked with Robert Kramer at Emergent BioSolutions in 2020.

2020

Fuad El-Hibri

Emergent BioSolutions

Chairman

2020

Richard Lindahl

Emergent BioSolutions

Chief Financial Officer

2020

Adam Havey

Emergent BioSolutions

Executive Vice President, Business Operations

2020

Atul Saran

Emergent BioSolutions

General Counsel

News

You may also like